Olema Pharmaceuticals (OLMA)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	35.89 mm	35.89 mm	35.89 mm	35.89 mm	35.89 mm	35.89 mm
Cash burn (monthly)	(no burn)	6.79 mm	12.54 mm	11.33 mm	9.01 mm	8.05 mm
Cash used (since last report)	n/a	29.20 mm	53.90 mm	48.68 mm	38.71 mm	34.58 mm
Cash remaining	n/a	6.69 mm	-18.01 mm	-12.79 mm	-2.82 mm	1.31 mm
Runway (months of cash)	n/a	1.0	-1.4	-1.1	-0.3	0.2

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

OLMA institutional ownership history Ownership history

99.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	131	127	+3.1%
Opened positions	21	32	-34.4%
Closed positions	17	29	-41.4%
Increased positions	47	48	-2.1%
Reduced positions	41	33	+24.2%

13F shares	Current	Prev Q	Change
Total value	696.53 bn	625.39 bn	+11.4%
Total shares	67.80 mm	67.02 mm	+1.2%
Total puts	23.10 k	34.00 k	-32.1%
Total calls	141.40 k	57.50 k	+145.9%
Total put/call ratio	0.2	0.6	-72.4%

Largest owners	Shares	Value	Change
Biotechnology Value Fund L P	9.14 mm	$109.36 mm	0.0%
BVF	9.14 mm	$109.08 bn	0.0%
Paradigm Biocapital Advisors	5.50 mm	$65.71 bn	-30.4%
Deep Track Capital	4.00 mm	$47.76 bn	0.0%
BlackRock	3.85 mm	$45.94 bn	NEW
Point72 Asset Management	3.69 mm	$44.03 bn	+14.8%
Logos Global Management	3.21 mm	$38.31 bn	0.0%
MPM Oncology Impact Management	2.68 mm	$32.01 bn	+1.0%
Vanguard	2.53 mm	$30.24 bn	-7.6%
STT State Street	1.97 mm	$23.52 bn	+1.1%

Largest transactions	Shares	Bought/sold	Change
BLK BlackRock	0.00	-4.00 mm	EXIT
BlackRock	3.85 mm	+3.85 mm	NEW
Paradigm Biocapital Advisors	5.50 mm	-2.40 mm	-30.4%
Pictet Asset Management Holding	1.67 mm	+1.67 mm	NEW
Citadel Advisors	1.25 mm	+1.12 mm	+847.2%
Polar Capital	0.00	-1.00 mm	EXIT
Balyasny Asset Management	709.10 k	+709.10 k	NEW
Woodline Partners	1.35 mm	+501.63 k	+58.8%
Point72 Asset Management	3.69 mm	+475.45 k	+14.8%
Candriam Luxembourg S.C.A.	1.51 mm	+448.09 k	+42.3%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

OLMA insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
10 Jan 25	Partners L P/il BVF	Common stock, $0.0001 par value	Sale back to company	Dispose D	No	No	0	22,740	0.00	347,970
10 Jan 25	Partners L P/il BVF	Common stock, $0.0001 par value	Sale back to company	Dispose D	No	No	0	161,810	0.00	2,003,966
10 Jan 25	Partners L P/il BVF	Common stock, $0.0001 par value	Sale back to company	Dispose D	No	No	0	235,450	0.00	2,655,977
10 Jan 25	Partners L P/il BVF	Pre-Funded Warrant Common stock, $0.0001 par value	Grant	Acquire A	No	No	0.0001	22,740	2.27	336,288
10 Jan 25	Partners L P/il BVF	Pre-Funded Warrant Common stock, $0.0001 par value	Grant	Acquire A	No	No	0.0001	161,810	16.18	2,627,590
10 Jan 25	Partners L P/il BVF	Pre-Funded Warrant Common stock, $0.0001 par value	Grant	Acquire A	No	No	0.0001	235,450	23.55	3,291,004
10 Jan 25	Bain Capital Life Sciences Investors	Common Stock	Other	Dispose J	Yes	No	0	3,500,000	0.00	4,300,000
10 Jan 25	Bain Capital Life Sciences Investors	Pre-Funded Warrant Common Stock	Other	Acquire J	Yes	No	0.0001	3,500,000	350.00	3,500,000
8 Jan 25	Bain Capital Life Sciences Investors	Common Stock	Buy	Acquire P	Yes	No	5.7579	300,000	1.73 mm	7,800,000
17 Dec 24	Graham G. Walmsley	Common Stock	Buy	Dispose P	Yes	No	6.75	700,761	4.73 mm	1,408,875